Contrast‐enhanced MRI for quantification of myocardial viability

During the past 10 years substantial advances have taken place in magnetic resonance imaging (MRI) capabilities and in contrast media development. Furthermore, knowledge of in vivo contrast media interactions with surrounding water and distribution into tissue has increased, permitting regional quantification of concentration‐time profiles in the myocardium. The combination of these advances has substantially improved the capability of contrast‐enhanced MRI characterization of myocardial ischemic injury, including its ability to discriminate viable from nonviable zones. Discrimination of viable from nonviable myocardial subregions is important for patient management and for research applications. This review addresses recent progress toward the goal of defining viable and nonviable myocardium based on MRI detection of contrast media effects. J. Magn. Reson. Imaging 1999;10:694–702. © 1999 Wiley‐Liss, Inc.

[1]  N. Lassen,et al.  Tracer kinetic methods in medical physiology , 1979 .

[2]  Maythem Saeed,et al.  Reperfused myocardial infarctions on T1‐ and susceptibility‐enhanced MRI: Evidence for loss of compartmentalization of contrast media , 1994, Magnetic resonance in medicine.

[3]  R. Kloner,et al.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.

[4]  C. Higgins,et al.  Alterations in T 1 of normal and reperfused infarcted myocardium after Gd‐BOPTA versus GD‐DTPA on inversion recovery EPI† , 1997, Magnetic resonance in medicine.

[5]  C. Kramer,et al.  Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. , 1999, Circulation.

[6]  A. Roos,et al.  Low-dosage dobutamine magnetic resonance imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction. , 1995, American heart journal.

[7]  C. Higgins,et al.  Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. , 1999, Radiology.

[8]  B R Rosen,et al.  Dynamic Gd‐DTPA enhanced MRI measurement of tissue cell volume fraction , 1995, Magnetic resonance in medicine.

[9]  C. Higgins,et al.  Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP--enhanced MR imaging. , 1989, Radiology.

[10]  C. Sotak,et al.  Quantitative dependence of MR signal intensity on tissue concentration of Gd(HP-DO3A) in the nephrectomized rat. , 1992, Magnetic resonance imaging.

[11]  N. Yamada,et al.  Serial assessment of myocardial infarction by using gated MR imaging and Gd-DTPA. , 1989, AJR. American journal of roentgenology.

[12]  S B Reeder,et al.  Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. , 1997, Circulation.

[13]  F. Prato,et al.  The determination of myocardial viability using Gd‐DTPA in a canine model of acute myocardial ischemia and reperfusion , 1996, Magnetic resonance in medicine.

[14]  E. McVeigh,et al.  A magnetization‐driven gradient echo pulse sequence for the study of myocardial perfusion , 1995, Magnetic resonance in medicine.

[15]  U. Sechtem,et al.  Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. , 1995, Circulation.

[16]  L. Becker,et al.  Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. , 1989, Circulation.

[17]  E. Erdmann,et al.  Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. , 1998, Journal of the American College of Cardiology.

[18]  K. Yu,et al.  Identification of Myocardial Reperfusion With Echo Planar Magnetic Resonance Imaging: Discrimination Between Occlusive and Reperfused Infarctions , 1994, Circulation.

[19]  C. Lorenz,et al.  Regional measurement of the Gd‐DTPA tissue partition coefficient in canine myocardium , 1997, Magnetic resonance in medicine.

[20]  L. Vander Elst,et al.  Spectroscopic and metabolic effects of MnCl2 and MnDPDP on the isolated and perfused rat heart. , 1997, Investigative radiology.

[21]  R. Judd,et al.  Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. , 1995, Circulation.

[22]  Jeroen J. Bax,et al.  Assessment of tissue viability: clinical demand and problems. , 1998, European heart journal.

[23]  P. V. van Dijkman,et al.  Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. , 1991, Radiology.

[24]  A L Baert,et al.  Paramagnetic metalloporphyrins: from enhancers of malignant tumors to markers of myocardial infarcts. , 1996, Academic radiology.

[25]  J Bogaert,et al.  Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. , 1999, Circulation.

[26]  A L Baert,et al.  Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis. , 1997, Investigative radiology.

[27]  C. Higgins,et al.  Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. , 1999, Radiology.

[28]  E. Erdmann,et al.  Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. , 1996, The American journal of cardiology.

[29]  J. Ardenkjaer-Larsen,et al.  Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties? , 1999, Biochemical and biophysical research communications.

[30]  F. Prato,et al.  Measurement of the extraction efficiency and distribution volume for Gd‐DTPA in normal and diseased canine myocardium , 1993, Magnetic resonance in medicine.

[31]  M. Laks,et al.  Comparison of electron beam computed tomography scanning and magnetic resonance imaging quantification of right ventricular mass: validation with autopsy weights. , 1996, Academic radiology.

[32]  C. Higgins,et al.  Identification of Myocardial Cell Death in Reperfused Myocardial Injury Using Dual Mechanisms of Contrast-Enhanced Magnetic Resonance Imaging , 1994 .

[33]  F. Prato,et al.  Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd‐DTPA: Kinetic modeling in canine ischemic disease , 1992, Magnetic resonance in medicine.

[34]  S. Kety.  The theory and applications of the exchange of inert gas at the lungs and tissues. , 1951, Pharmacological reviews.

[35]  F. C. Dougherty,et al.  Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium‐DTPA , 1986, Clinical cardiology.

[36]  G. Bačić,et al.  Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn‐DPDP , 1996, Magnetic resonance in medicine.

[37]  W J Manning,et al.  Studies of Gd‐DTPA relaxivity and proton exchange rates in tissue , 1994, Magnetic resonance in medicine.

[38]  A L Baert,et al.  Localization of metalloporphyrin-induced "specific" enhancement in experimental liver tumors: comparison of magnetic resonance imaging, microangiographic, and histologic findings. , 1995, Academic radiology.

[39]  J Sykes,et al.  Assessment of myocardial viability using MRI during a constant infusion of Gd‐DTPA: Further studies at early and late periods of reperfusion , 1999, Magnetic resonance in medicine.

[40]  H. Brurok,et al.  Effects of MnDPDP, DPDP--, and MnCl2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart. , 1997, Investigative radiology.

[41]  F. Prato,et al.  Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentate dimeglumine , 1993, Magnetic resonance in medicine.

[42]  E. Atalar,et al.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. , 1995, Circulation.

[43]  R M Weisskoff,et al.  Water diffusion and exchange as they influence contrast enhancement , 1997, Journal of magnetic resonance imaging : JMRI.

[44]  E R McVeigh,et al.  Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. , 1998, Circulation.

[45]  A. Roos,et al.  Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. , 1998, American heart journal.

[46]  Katherine C. Wu,et al.  Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. , 1998, Journal of the American College of Cardiology.

[47]  C. Higgins,et al.  Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate, Mn-DPDP. , 1989, Investigative radiology.

[48]  E. Fleck,et al.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. , 1999, Circulation.